MTA3 and hepatocellular carcinoma: Tunicamycin exerts antitumor effects by modulating the miR-22-3p/MTA3 axis (40), whereas the transient receptor potential channel TRPC1 may promote HCC progression by upregulating MTA3 and other associated genes (41), highlighting its central role in complex regulatory networks.